Exploring the genetics and non-cell autonomous mechanisms underlying ALS/FTLD
暂无分享,去创建一个
[1] M. Molloy,et al. Pathogenic mutation in the ALS/FTD gene, CCNF, causes elevated Lys48-linked ubiquitylation and defective autophagy , 2019, Cellular and Molecular Life Sciences.
[2] Markus Glatzel,et al. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases. , 2017, Immunity.
[3] M. Mesulam,et al. TIA1 Mutations in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Promote Phase Separation and Alter Stress Granule Dynamics , 2017, Neuron.
[4] Nick C Fox,et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease , 2017, Nature Genetics.
[5] O. Hardiman,et al. Edaravone: a new treatment for ALS on the horizon? , 2017, The Lancet Neurology.
[6] Y. Itoyama,et al. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial , 2017, The Lancet Neurology.
[7] I. Amit,et al. A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease , 2017, Cell.
[8] P. Andersen,et al. Association of Mutations in TBK1 With Sporadic and Familial Amyotrophic Lateral Sclerosis and Frontotemporal Dementia , 2017, JAMA neurology.
[9] Nicole R. Zürcher,et al. Glial activation colocalizes with structural abnormalities in amyotrophic lateral sclerosis , 2016, Neurology.
[10] Diana M. Mitrea,et al. C9orf72 Dipeptide Repeats Impair the Assembly, Dynamics, and Function of Membrane-Less Organelles , 2016, Cell.
[11] L. Petrucelli,et al. Poly(GR) in C9ORF72-Related ALS/FTD Compromises Mitochondrial Function and Increases Oxidative Stress and DNA Damage in iPSC-Derived Motor Neurons , 2016, Neuron.
[12] M. Mann,et al. C9ORF72 interaction with cofilin modulates actin dynamics in motor neurons , 2016, Nature Neuroscience.
[13] C. Mcdermott,et al. Supportive and symptomatic management of amyotrophic lateral sclerosis , 2016, Nature Reviews Neurology.
[14] Junying Yuan,et al. RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS , 2016, Science.
[15] Ying Sun,et al. Association Between Progranulin and Gaucher Disease , 2016, EBioMedicine.
[16] Steffen Jung,et al. Age-related myelin degradation burdens the clearance function of microglia during aging , 2016, Nature Neuroscience.
[17] L. Hayward,et al. ALS mutant SOD1 interacts with G3BP1 and affects stress granule dynamics , 2016, Acta Neuropathologica.
[18] F. Peri,et al. Developmental Apoptosis Mediates Entry and Positioning of Microglia in the Zebrafish Brain. , 2016, Cell reports.
[19] Annelot M. Dekker,et al. NEK1 variants confer susceptibility to amyotrophic lateral sclerosis , 2016, Nature Genetics.
[20] Annelot M. Dekker,et al. Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis , 2017 .
[21] M. Oulad-Abdelghani,et al. Loss of C9ORF72 impairs autophagy and synergizes with polyQ Ataxin‐2 to induce motor neuron dysfunction and cell death , 2016, The EMBO journal.
[22] E. Holzbaur,et al. Dynamic recruitment and activation of ALS-associated TBK1 with its target optineurin are required for efficient mitophagy , 2016, Proceedings of the National Academy of Sciences.
[23] M. Smolka,et al. The ALS/FTLD associated protein C9orf72 associates with SMCR8 and WDR41 to regulate the autophagy-lysosome pathway , 2016, Acta neuropathologica communications.
[24] E. Beghi,et al. Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis , 2016, International journal of epidemiology.
[25] Ben A. Barres,et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models , 2016, Science.
[26] Michelle K. Cahill,et al. Progranulin Deficiency Promotes Circuit-Specific Synaptic Pruning by Microglia via Complement Activation , 2016, Cell.
[27] D. Borchelt,et al. C9orf72 BAC Mouse Model with Motor Deficits and Neurodegenerative Features of ALS/FTD , 2016, Neuron.
[28] T. Wieland,et al. NEK1 mutations in familial amyotrophic lateral sclerosis. , 2016, Brain : a journal of neurology.
[29] Benjamin E. L. Lauffer,et al. Untangling the brain's neuroinflammatory and neurodegenerative transcriptional responses , 2016, Nature Communications.
[30] Robert H. Brown,et al. CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia , 2016, Nature Communications.
[31] Eric E. Smith,et al. The Prevalence and Incidence of Frontotemporal Dementia: a Systematic Review , 2016, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[32] Sebastian A. Wagner,et al. Phosphorylation of OPTN by TBK1 enhances its binding to Ub chains and promotes selective autophagy of damaged mitochondria , 2016, Proceedings of the National Academy of Sciences.
[33] L. Petrucelli,et al. C9ORF72 poly(GA) aggregates sequester and impair HR23 and nucleocytoplasmic transport proteins , 2016, Nature Neuroscience.
[34] D. Underhill,et al. C9orf72 is required for proper macrophage and microglial function in mice , 2016, Science.
[35] Mark Ellisman,et al. NF-κB Restricts Inflammasome Activation via Elimination of Damaged Mitochondria , 2016, Cell.
[36] Anthony R White,et al. Advances in the Development of Disease-Modifying Treatments for Amyotrophic Lateral Sclerosis , 2016, CNS Drugs.
[37] H. Horvitz,et al. Human C9ORF72 Hexanucleotide Expansion Reproduces RNA Foci and Dipeptide Repeat Proteins but Not Neurodegeneration in BAC Transgenic Mice , 2015, Neuron.
[38] L. Petrucelli,et al. C9orf72 BAC Transgenic Mice Display Typical Pathologic Features of ALS/FTD , 2015, Neuron.
[39] D. Rujescu,et al. The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease , 2015, Alzheimer's & Dementia.
[40] A. Aulas,et al. Alterations in stress granule dynamics driven by TDP-43 and FUS: a link to pathological inclusions in ALS? , 2015, Front. Cell. Neurosci..
[41] Jennifer Luebke,et al. Depletion of microglia and inhibition of exosome synthesis halt tau propagation , 2015, Nature Neuroscience.
[42] Keith A. Johnson,et al. Modulation of TREM2 by CD33: a protein QTL study integrates Alzheimer loci in human monocytes , 2015, Nature Neuroscience.
[43] A. Kanagaraj,et al. Phase Separation by Low Complexity Domains Promotes Stress Granule Assembly and Drives Pathological Fibrillization , 2015, Cell.
[44] Marco Y. Hein,et al. A Liquid-to-Solid Phase Transition of the ALS Protein FUS Accelerated by Disease Mutation , 2015, Cell.
[45] J. Burman,et al. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy , 2015, Nature.
[46] N. Hattori,et al. TBK1 controls autophagosomal engulfment of polyubiquitinated mitochondria through p62/SQSTM1 phosphorylation. , 2015, Human molecular genetics.
[47] M. Monteiro,et al. Defective Proteasome Delivery of Polyubiquitinated Proteins by Ubiquilin-2 Proteins Containing ALS Mutations , 2015, PloS one.
[48] Kevin F. Bieniek,et al. C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits , 2015, Science.
[49] S. Quake,et al. A survey of human brain transcriptome diversity at the single cell level , 2015, Proceedings of the National Academy of Sciences.
[50] Peter K. Stys,et al. Inefficient clearance of myelin debris by microglia impairs remyelinating processes , 2015, The Journal of experimental medicine.
[51] Brittany N. Lasseigne,et al. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways , 2015, Science.
[52] T. Wieland,et al. Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia , 2015, Nature Neuroscience.
[53] J. Hardy,et al. SnapShot: Genetics of ALS and FTD , 2015, Cell.
[54] Manolis Kellis,et al. Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer’s disease , 2015, Nature.
[55] Frank Baas,et al. Molecular classification of amyotrophic lateral sclerosis by unsupervised clustering of gene expression in motor cortex , 2015, Neurobiology of Disease.
[56] Bruce R. Rosen,et al. Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: Assessed with [11C]-PBR28 , 2015, NeuroImage: Clinical.
[57] Timothy A. Miller,et al. Amyotrophic lateral sclerosis onset is influenced by the burden of rare variants in known amyotrophic lateral sclerosis genes , 2015, Annals of neurology.
[58] F. Geissmann,et al. Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors , 2014, Nature.
[59] C. Limatola,et al. Modulating neurotoxicity through CX3CL1/CX3CR1 signaling , 2014, Front. Cell. Neurosci..
[60] S. Finkbeiner,et al. Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models , 2014, Nature chemical biology.
[61] Daphne Koller,et al. Polarization of the Effects of Autoimmune and Neurodegenerative Risk Alleles in Leukocytes , 2014, Science.
[62] A. Pestronk,et al. TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis. , 2014, JAMA neurology.
[63] Lorne Zinman,et al. Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis , 2014, Nature Neuroscience.
[64] Dorian B. McGavern,et al. Microglia development and function. , 2014, Annual review of immunology.
[65] Guy C. Brown,et al. Microglial phagocytosis of live neurons , 2014, Nature Reviews Neuroscience.
[66] Mackenzie W. Mathis,et al. Necroptosis Drives Motor Neuron Death in Models of Both Sporadic and Familial ALS , 2014, Neuron.
[67] Patrick G. Shaw,et al. C9orf72 Nucleotide Repeat Structures Initiate Molecular Cascades of Disease , 2014, Nature.
[68] P. Gleeson,et al. C9ORF72, implicated in amytrophic lateral sclerosis and frontotemporal dementia, regulates endosomal trafficking , 2014, Human molecular genetics.
[69] R. Kacimi,et al. Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) Deficiency Attenuates Phagocytic Activities of Microglia and Exacerbates Ischemic Damage in Experimental Stroke , 2015, The Journal of Neuroscience.
[70] J. Ule,et al. Hexanucleotide Repeats in ALS/FTD Form Length-Dependent RNA Foci, Sequester RNA Binding Proteins, and Are Neurotoxic , 2013, Cell reports.
[71] Nipun A. Mistry,et al. RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention , 2013, Neuron.
[72] D. Cleveland,et al. Converging Mechanisms in ALS and FTD: Disrupted RNA and Protein Homeostasis , 2013, Neuron.
[73] M. Rossor,et al. Frontotemporal dementia , 2013, The BMJ.
[74] R. Myers,et al. A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model. , 2013, Cell reports.
[75] L. Tran,et al. Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease , 2013, Cell.
[76] Matthew H. Bailey,et al. GWAS of Cerebrospinal Fluid Tau Levels Identifies Risk Variants for Alzheimer’s Disease , 2013, Neuron.
[77] M. Ishii,et al. Layer V cortical neurons require microglial support for survival during postnatal development , 2013, Nature Neuroscience.
[78] E. Kremmer,et al. The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS , 2013, Science.
[79] Michael Benatar,et al. Prion-like domain mutations in hnRNPs cause multisystem proteinopathy and ALS , 2013, Nature.
[80] Y. Li,et al. Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis , 2013, Nature Neuroscience.
[81] Kevin F. Bieniek,et al. Unconventional Translation of C9ORF72 GGGGCC Expansion Generates Insoluble Polypeptides Specific to c9FTD/ALS , 2013, Neuron.
[82] R. Baloh. How do the RNA-binding proteins TDP-43 and FUS relate to amyotrophic lateral sclerosis and frontotemporal degeneration, and to each other? , 2012, Current opinion in neurology.
[83] A. Chiò,et al. Extensive genetics of ALS , 2012, Neurology.
[84] F. Jessen,et al. A Pan-European Study of the C9orf72 Repeat Associated with FTLD: Geographic Prevalence, Genomic Instability, and Intermediate Repeats , 2012, Human mutation.
[85] H. Weiner,et al. Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. , 2012, The Journal of clinical investigation.
[86] Steven B. Bradfute,et al. TBK-1 promotes autophagy-mediated antimicrobial defense by controlling autophagosome maturation. , 2012, Immunity.
[87] Michelle K. Lupton,et al. Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. , 2012, Human molecular genetics.
[88] P. Rossini,et al. Contribution of major amyotrophic lateral sclerosis genes to the etiology of sporadic disease , 2012, Neurology.
[89] J. Trojanowski,et al. Microglial Activation Correlates with Disease Progression and Upper Motor Neuron Clinical Symptoms in Amyotrophic Lateral Sclerosis , 2012, PloS one.
[90] S. C. Chafe,et al. Mutations in the Profilin 1 Gene Cause Familial Amyotrophic Lateral Sclerosis , 2012, Nature.
[91] C. Cheroni,et al. Dysfunction of constitutive and inducible ubiquitin-proteasome system in amyotrophic lateral sclerosis: Implication for protein aggregation and immune response , 2012, Progress in Neurobiology.
[92] M. Vivanco,et al. Early Functional Deficit and Microglial Disturbances in a Mouse Model of Amyotrophic Lateral Sclerosis , 2012, PloS one.
[93] Janel O. Johnson,et al. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study , 2012, The Lancet Neurology.
[94] S. Servidei,et al. P525L FUS mutation is consistently associated with a severe form of juvenile Amyotrophic Lateral Sclerosis , 2012, Neuromuscular Disorders.
[95] S. Pereson,et al. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study , 2012, The Lancet Neurology.
[96] S. Ajroud‐Driss,et al. SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. , 2011, Archives of neurology.
[97] Bruce L. Miller,et al. Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS , 2011, Neuron.
[98] David Heckerman,et al. A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD , 2011, Neuron.
[99] M. Giustetto,et al. Synaptic Pruning by Microglia Is Necessary for Normal Brain Development , 2011, Science.
[100] J. Hodges,et al. Motor neuron dysfunction in frontotemporal dementia. , 2011, Brain : a journal of neurology.
[101] J. Haines,et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult onset ALS and ALS/dementia , 2011, Nature.
[102] Pico Caroni,et al. Selective Neuronal Vulnerability in Neurodegenerative Diseases: from Stressor Thresholds to Degeneration , 2011, Neuron.
[103] E. Schomburg,et al. In vivo imaging reveals rapid morphological reactions of astrocytes towards focal lesions in an ALS mouse model , 2011, Neuroscience Letters.
[104] Patrizia Sola,et al. Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS , 2011, Neuron.
[105] John Q. Trojanowski,et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS , 2010, Nature.
[106] Deepak Srinivasan,et al. Ubiquilin functions in autophagy and is degraded by chaperone-mediated autophagy. , 2010, Human molecular genetics.
[107] Takeo Kato,et al. Mutations of optineurin in amyotrophic lateral sclerosis , 2010, Nature.
[108] Bruce L. Miller,et al. Frontotemporal lobar degeneration , 2010, CNS drugs.
[109] H. Kretzschmar,et al. A new subtype of frontotemporal lobar degeneration with FUS pathology. , 2009, Brain : a journal of neurology.
[110] D. Borchelt,et al. Variation in aggregation propensities among ALS-associated variants of SOD1: Correlation to human disease , 2009, Human molecular genetics.
[111] A. Gitler,et al. TDP-43 Is Intrinsically Aggregation-prone, and Amyotrophic Lateral Sclerosis-linked Mutations Accelerate Aggregation and Increase Toxicity* , 2009, The Journal of Biological Chemistry.
[112] L. Goldstein,et al. SOD1 and cognitive dysfunction in familial amyotrophic lateral sclerosis , 2009, Journal of Neurology.
[113] Xun Hu,et al. Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6 , 2009, Science.
[114] J L Haines,et al. Supporting Online Material Materials and Methods Figs. S1 to S7 Tables S1 to S4 References Mutations in the Fus/tls Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis , 2022 .
[115] N. Cairns,et al. ALS and FTLD: two faces of TDP‐43 proteinopathy , 2008, European journal of neurology.
[116] H. Neumann,et al. Debris clearance by microglia: an essential link between degeneration and regeneration , 2008, Brain : a journal of neurology.
[117] C. Nüsslein-Volhard,et al. Live Imaging of Neuronal Degradation by Microglia Reveals a Role for v0-ATPase a1 in Phagosomal Fusion In Vivo , 2008, Cell.
[118] Xun Hu,et al. TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis , 2008, Science.
[119] D. Gutmann,et al. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis , 2008, Nature Neuroscience.
[120] G. Bjørkøy,et al. p62/SQSTM1 Binds Directly to Atg8/LC3 to Facilitate Degradation of Ubiquitinated Protein Aggregates by Autophagy* , 2007, Journal of Biological Chemistry.
[121] J. Schneider,et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration , 2007, Acta Neuropathologica.
[122] J. Trojanowski,et al. Pathological TDP‐43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations , 2007, Annals of neurology.
[123] Hynek Wichterle,et al. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons , 2007, Nature Neuroscience.
[124] J. Trojanowski,et al. Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model , 2007, Neuron.
[125] H. Akiyama,et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. , 2006, Biochemical and biophysical research communications.
[126] S. Mckercher,et al. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis , 2006, Proceedings of the National Academy of Sciences.
[127] Bruce L. Miller,et al. Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.
[128] C. Duijn,et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21 , 2006, Nature.
[129] S. Melquist,et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 , 2006, Nature.
[130] Hideyuki Okano,et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice , 2006, Nature.
[131] Masaaki Komatsu,et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice , 2006, Nature.
[132] G. Kollias,et al. Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia , 2006, Science.
[133] P. Monk,et al. Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis , 2005, Glia.
[134] S H Appel,et al. Prevalence and patterns of cognitive impairment in sporadic ALS , 2005, Neurology.
[135] G. Schellenberg,et al. Regulation of tau isoform expression and dementia. , 2005, Biochimica et biophysica acta.
[136] Elizabeth L Sampson,et al. In vivo detection of microglial activation in frontotemporal dementia , 2004, Annals of neurology.
[137] B. Ransom,et al. Increased cytotoxic potential of microglia from ALS‐transgenic mice , 2004, Glia.
[138] John W Griffin,et al. DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). , 2004, American journal of human genetics.
[139] R. Nussbaum,et al. Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1 , 2004, Science.
[140] F. Turkheimer,et al. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study , 2004, Neurobiology of Disease.
[141] Shin J. Oh,et al. Mutant dynactin in motor neuron disease , 2003, Nature Genetics.
[142] A. Kakita,et al. Neuropathology with Clinical Correlations of Sporadic Amyotrophic Lateral Sclerosis: 102 Autopsy Cases Examined Between 1962 and 2000 , 2003, Brain pathology.
[143] Catherine Lomen-Hoerth,et al. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia , 2002, Neurology.
[144] S. Appel,et al. Immune reactivity in a mouse model of familial ALS correlates with disease progression , 2001, Neurology.
[145] D. Neary,et al. Classification and Description of Frontotemporal Dementias , 2000, Annals of the New York Academy of Sciences.
[146] Takeshi Noda,et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing , 2000, The EMBO journal.
[147] R. Miller,et al. Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[148] A. Walling,et al. Amyotrophic lateral sclerosis: Lou Gehrig's disease. , 1999, American family physician.
[149] T. Iwaki,et al. Skein-like inclusions in the neostriatum from a case of amyotrophic lateral sclerosis with dementia , 1998, Acta Neuropathologica.
[150] S. Minoshima,et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.
[151] V. Meininger,et al. Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. , 1994, Human molecular genetics.
[152] Y. Ohsumi,et al. Isolation and characterization of autophagy‐defective mutants of Saccharomyces cerevisiae , 1993, FEBS letters.
[153] J. Haines,et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.
[154] S. Hirai,et al. Ubiquitin-positive intraneuronal inclusions in the extramotor cortices of presenile dementia patients with motor neuron disease , 1992, Journal of Neurology.
[155] D. Neary,et al. Hippocampal and neocortical ubiquitin-immunoreactive inclusions in amyotrophic lateral sclerosis with dementia , 1992, Neuroscience Letters.
[156] P. Mcgeer,et al. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. , 1992, The American journal of pathology.
[157] Yoichi Nakazato,et al. New ubiquitin-positive intraneuronal inclusions in the extra-motor cortices in patients with amyotrophic lateral sclerosis , 1991, Neuroscience Letters.
[158] J. Haines,et al. Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity. , 1991, The New England journal of medicine.
[159] S. Appel,et al. IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis. , 1990, Archives of neurology.
[160] R. Kuncl,et al. Amyotrophic lateral sclerosis: An unconventional autoimmune disease? , 1989, Annals of neurology.
[161] L. Rowland,et al. Amyotrophic Lateral Sclerosis , 1980, Neurology.
[162] G. Fraedrich,et al. Juvenile recurrent respiratory papillomatosis: Still a mystery disease with difficult management , 2007, Head & neck.
[163] R. Klausen,et al. Selective , 2020, Encyclopedia of the UN Sustainable Development Goals.
[164] W. Baumgärtner,et al. Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination. , 2013, Brain : a journal of neurology.
[165] J. Trojanowski,et al. Microglial activation and TDP-43 pathology correlate with executive dysfunction in amyotrophic lateral sclerosis , 2011, Acta Neuropathologica.
[166] M. Hayden,et al. Juvenile amyotrophic lateral sclerosis , 2020, Definitions.
[167] D. Klionsky,et al. Vacuolar import of proteins and organelles from the cytoplasm. , 1999, Annual review of cell and developmental biology.
[168] D. B. Williams,et al. Motor neuron disease (amyotrophic lateral sclerosis). , 1991, Mayo Clinic proceedings.